In an official statement, the university said that it is awaiting the results of a safety review from UK regulators, the Medicines and Healthcare products Regulatory Agency (MHRA), as reported by the Hill.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2RdMyNn
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Oxford halts dosing in trial of AstraZeneca COVID vaccine in children, teenagers
0 comments:
Post a Comment